AAD is developing platform technology, which can be used to identify diseases and infections earlier, faster and closer to the farm gate than any other technology today.
Imagine the savings for producers and consumers of animal agriculture if a rapid, on-farm test could diagnose diseases, infections and immune system status. We could save lives, increase productivity, protect investments and more. Today, tests are sent to a central lab and vets and producers wait – losing valuable time and creating logistical inefficiencies.
Tomorrow, AAD plans to put the power of information at the farm gate in minutes. Rapid, point-of-care detection of infection before symptoms appear will enable earlier intervention by producers and veterinarians. For example, our first on-farm diagnostic, the SCC+™ System can indicate whether an animal requires immediate treatment or is safe for further transport or processing. Vets, owners, and businesses are expected to save millions in time and total operating costs each year.
Mastitis is merely the first application. AAD is developing platform technology, which can be used to identify diseases and infections earlier, faster and closer to the farm gate than any other technology today. In addition to milk, we can build future applications to analyze blood, urine, feces and any other bodily fluid needed to provide rapid, valuable diagnostics for the vet and producer.
Our analysis is more reliable than many other measures because we rely on the body’s own immune response to identify and stage diseases. For example, in our first application, the SCC+ System, we identify mastitis at the earliest, subclinical stage even in the cow’s first milk. No other on-farm tool can do this for mastitis. This is just the beginning.
The companion animal laboratory diagnostic segment has grown exponentially in the past few years because companion animals are easily transported to a clinic, which has extensive testing facilities and specialists in a controlled environment. However, the emerging farm animal lab diagnostic segment remains untapped, primarily because suitable mobile technology hasn’t been available.
The overall animal diagnostic segment exceeds $1 billion annually and continues to have solid growth prospects. With few major players in this fragmented market, and even fewer focusing on on-site health for valuable farm animals, AAD is poised to become the leading developer of diagnostic systems for valuable farm animals.